SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 212.11 |
| Enterprise Value ($M) | 44.04 |
| Book Value ($M) | 150.29 |
| Book Value / Share | 2.85 |
| Price / Book | 1.41 |
| NCAV ($M) | -13.35 |
| NCAV / Share | -0.25 |
| Price / NCAV | -15.88 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.80 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -0.73 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.72 |
| Current Ratio | 6.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 171.94 |
| Assets | 335.58 |
| Liabilities | 185.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -186.85 |
| Net Income | -176.21 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -117.32 |
| Cash from Investing | -0.76 |
| Cash from Financing | 0.50 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 4.40 | -42.92 | |
| 13G/A | Perlroth Victor | 11.00 | 7.05 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 96,394 | 292,808 | 32.92 | |
| 40,236 | 239,839 | 16.78 | |
| 69,255 | 220,238 | 31.45 | |
| 80,883 | 320,229 | 25.26 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| JANX – Janux Therapeutics, Inc. | KALV – KalVista Pharmaceuticals, Inc. |
| KLTO – Klotho Neurosciences, Inc. | KROS – Keros Therapeutics, Inc. |
| KYMR – Kymera Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io